期刊文献+

右美托咪定预输注对双管喉罩置入时血流动力学影响的研究 被引量:5

Effects of different doses of dexmedetomidine on the hemodynamics changes when inserted with Supreme laryngeal mask airway before anesthesia
下载PDF
导出
摘要 目的观察右美托咪定(dexmedetomidine,DEX)预输注对双管喉罩置入时血流动力学和机体应激反应的影响。方法选择择期行全麻手术的患者60例,ASA分级Ⅰ~Ⅱ级,采用随机数字表法将其分为对照组(C组)、DEXl组(D1组)和DEX2组(1)2组),每组各20例。患者术前未使用任何药物,C组给予等容量的生理盐水,D1组和D2组麻醉前10min分别给予DEX0.5、1μg·kg-1(均用生理盐水稀释至4mg·L-1)静脉输注,输注时间均为10min。10min后以依托咪酯乳剂0.2mg·kg-1、舒芬太尼0.15μg·kg-1、阿曲库铵0.5mg·kg。静脉诱导。3组患者均用利多卡因喷壶充分咽后壁表面麻醉下双管喉罩置入,根据患者体重范围结合患者的身体情况,选择适宜型号的一次性双管喉罩,常规仔细检查双管喉罩气囊是否漏气,在罩体背侧及前侧涂抹少量石蜡油,以减少双管喉罩在插入过程中的阻力。记录3组置入双管喉罩前、置入双管喉罩即刻及置入双管喉罩后1rain心率和平均动脉压(MAP),比较3组不同时点的MAP、心率的变化率。结果D1组和D2组置入双管喉罩前、置入双管喉罩即刻及置入双管喉罩后1rain血流动力学变化明显小于C组(P〈0.05);与D1组比较,D2组置入双管喉罩前、置入双管喉罩即刻及置入双管喉罩后1rain的心率变化率均较大(P〈0.05)。结论麻醉开始前静脉预输注DEX0.5μg·kg-1和1μg·kg-1联合充分咽后壁表面麻醉能够明显抑制置入双管喉罩所引起的血流动力学变化。其中静脉预输注DEX0.5μg·kg-1的患者双管喉罩置入时血流动力学更稳定,而预输注DEX1μg·kg-1的患者在充分咽后壁表面麻醉下,心率往往受到抑制。 Objective To observe the effecte of different doses of dexmedetomidine (DEX) on hemodynamics changes and stress response when inserted with Supreme laryngeal mask airway (LMA Suprem) before anesthesia. Methods A total of 60 ASAⅠ~Ⅱ patients who were scheduled for general anesthesia were randomly divided into three groups (n = 20) : a control group (Group C) , a DEX intravenous infusion 1 group (Group D1 ) and a DEX intravenous infusion 2 group (Group D2 ). Patients did not received any medication before surgery. Groups D1 and D2 were administrated with 0. 5 and 1 μg·kg-1 of DEX ( diluted to 4 mg·kg-1with normal saline) over 10 min, which Group C was adminis- trated with the equal volume of normal saline. Then, patients underwent intravenous induction using 0.2 mg·kg-1eto- midate, 0.15 μg·kg-1 sufentanil and 0.5 mg·kg-1 atracurium. All patients were inserted with LMA Supreme under pharyngeal surface anesthesia of lidocaine. Based on body weight and basic physical condition, proper types of Supreme LMA were chosen. The changes of heart rate (HR) and mean blood pressure (MAP) before, immediately after and 1 min after LMA Supreme insertion were recorded. Results Compared with Group C, Groups D1 and D2 showed remark- ably decreased hemodynamic changes before, immediately and 1 rain after LMA Supreme insertion (P 〈 0.05). However, Compared with Group D1, the change of HR was increased in Group 1)2 before, immediately and 1 rain after LMA Supreme insertion (P 〈 0.05). Conclusions DEX (0.5 or 1μg·kg-1 ) intravenous infusion before anesthesia combined with pharyngeal surface anesthesia can significantly suppress hemodynamic changes after the LMA Supreme inser-tion. Administration of 0.5μg·kg-1 DEX can successfully reduce the hemodynamic changes. HR is suppressed after 1 μg·kg-1 DEX infusion under pharyngeal surface anesthesia.
作者 高芳
出处 《徐州医科大学学报》 CAS 2017年第12期825-828,共4页 Journal of Xuzhou Medical University
基金 徐州市科技创新项目(KC16SH117)
关键词 右美托咪定 双管喉罩 血流动力学 dexmedetomidine Supreme laryngeal mask airway hemodynamics
  • 相关文献

参考文献1

二级参考文献39

  • 1[1]Khan ZP,Ferguson CN,Jones RM.Alpha-2 and imidazoline receptor agonists:their pharmacology and therapeutic role[J].Anesthesia,1999;54:146-165.
  • 2[2]Kamibayashi T,Maze M.Clinical uses of alpha 2-adrenergic agonists[J].Anesthesiology,2000;93:1345-1350.
  • 3[3]Calzada BC,De Artinano AA.[alpha]2-Adrenoreceptor subtypes[J].Pharmacol Res,2001;44:195-208.
  • 4[4]Hunter JC,Fontanna DJ,Hedley LR,et al.Assessment of the role of alpha 2-adrenoceptor subtypes in the antinociceptive,sedative and hypothermic action of dexmedetomidine in transgenic mice[J].Br J Pharmacol,1997;122:1339-1344.
  • 5[5]Nelson LE,Lu J,Guo TZ,et al.The α2-Adrenoceptor agonist dexmedetomidine converges on an endogenous sleep-promoting pathway to exert its sedative effects[J].Anesthesiology,2003;98:428-436.
  • 6[6]Coull JT,Jones M,Egan T,et al.Attentionla effects of noradranaline vary with arousal level:selective activation of thalamie pulvinar in humans[J].Neuro Image,2004;22:315-322.
  • 7[7]Eisenach JC.[Alpha]2 agonists and analgesia[J].Exp Opin Invest Drugs,1994;3:1005-1010.
  • 8[8]Ma D,Rajakumamswamy N,Maze M.Alpha2-Adrenoceptor agonists:shedding light on neuroprotection?[J].Br Med Bull,2005;71:77-92.
  • 9[9]Ebert TJ,Hall JE,Barney JA,et al.The effects of increasing plasma concentrations of dexmedetomidine in humans[J].Anesthesiology,2000;93:382-394.
  • 10[10]Ramsey MA,Luterman DL.Dexmedetomidine as a total intravenous anesthestic agent[J].Anesthesiology,2004;101:787-781.

共引文献482

同被引文献50

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部